Bial Overview

  • Year Founded
  • 1924

Year Founded

  • Status
  • Private

  • Employees
  • 968

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Financing Rounds
  • 3

  • Investments
  • 4

Bial General Information

Description

Operator of a pharmaceutical company intended to discover, develop, and provide therapeutic technologies for Parkinson's and epilepsy diseases. The company's technology contributes to the construction of a knowledgeable society, one that is competitive and operates with utmost integrity based on scientific development and innovation, enabling companies to invest in quality and innovation with proper excellence in scientific research.

Contact Information

Website
www.bial.com
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • Avenida da Siderurgia Nacional
  • S. Romão e S. Mamede
  • Coronado, 4745-457
  • Portugal
+351 22
Primary Industry
Pharmaceuticals
Corporate Office
  • Avenida da Siderurgia Nacional
  • S. Romão e S. Mamede
  • Coronado, 4745-457
  • Portugal
+351 22

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Bial Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Bial‘s full profile, request access.

Request a free trial

Bial Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Bial Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Bial‘s full profile, request access.

Request a free trial

Bial Investments & Acquisitions (4)

Bial’s most recent deal was a Merger/Acquisition with Lysosomal Therapeutics. The deal was made on 01-Oct-2020.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Lysosomal Therapeutics 01-Oct-2020 Merger/Acquisition Drug Discovery
BIAL-Sarm 12-Jul-2010 Merger/Acquisition Pharmaceuticals
Bial Aristegui 01-Jan-1998 Merger/Acquisition Biotechnology
GSK (Elebrato, Laventair, Revinty, Trelegy, Anoro & Relvar located in United Kingdom) Buyout/LBO Buildings and Property
To view Bial’s complete investments and acquisitions history, request access »

Bial Exits (1)

Bial’s most recent exit was on 01-Jan-1998 from Bial Aristegui. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Bial Aristegui 01-Jan-1998 Completed
To view Bial’s complete exits history, request access »

Bial FAQs

  • When was Bial founded?

    Bial was founded in 1924.

  • Where is Bial headquartered?

    Bial is headquartered in Coronado, Portugal.

  • What is the size of Bial?

    Bial has 968 total employees.

  • What industry is Bial in?

    Bial’s primary industry is Pharmaceuticals.

  • Is Bial a private or public company?

    Bial is a Private company.

  • What is Bial’s current revenue?

    The current revenue for Bial is .

  • Who are Bial’s investors?

    C2 Capital Partners (Portugal) has invested in Bial.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process